Longitude Capital
VC · Menlo Park · United States
Stages
Investment region
Industries
Profile
Longitude Capital is a venture capital firm headquartered in Menlo Park, California, and Boston, Massachusetts. Founded by Juliet Bakker, Patrick Enright, and others with extensive experience in life sciences investing, the firm specializes in venture growth investments within the healthcare industry, particularly in biotechnology, medical technology, and health solutions. The team is comprised of seasoned investors with a cumulative investing history of over two centuries, having collaborated on numerous investments and exits. Their approach distinguishes them by focusing on clinically de-risked assets and employing a range of investment vehicles. The firm invests in companies tackling various challenges in healthcare sectors such as biotechnology, medical technology, and health solutions. They target companies at both clinical and commercial stages, utilizing investment sizes adaptable to the venture growth strategy. Their geographic focus primarily lies in North America, boasting a total AUM of over $2 billion across six funds. Longitude Capital is known for its innovative investment strategies, including venture capital, asset spin-outs, and equity-linked instruments. Notable investments by Longitude Capital include Axonics Modulation Technologies - neuromodulation devices, PROCEPT BioRobotics - robotic surgical systems, Jazz Pharmaceuticals - specialty pharmaceuticals, and Insulet - diabetes care technology. The firm has demonstrated a history of successful exits and liquidity events, leveraging its broad industry network and strategic partnerships.
Kontakte (2)
| Name | Title | Telefon | ||
|---|---|---|---|---|
| Managing Director | — | — | — | |
| Principal | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.